Catalyst Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.About CPRX
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E.
CEOPatrick J. McEnany
CEOPatrick J. McEnany
Employees76
Employees76
HeadquartersCoral Gables, Florida
HeadquartersCoral Gables, Florida
Founded2002
Founded2002
Employees76
Employees76
CPRX Key Statistics
Market cap1.68B
Market cap1.68B
Price-Earnings ratio26.48
Price-Earnings ratio26.48
Dividend yield—
Dividend yield—
Average volume4.60M
Average volume4.60M
High today$16.22
High today$16.22
Low today$15.66
Low today$15.66
Open price$15.72
Open price$15.72
Volume1.69M
Volume1.69M
52 Week high$22.11
52 Week high$22.11
52 Week low$5.58
52 Week low$5.58
CPRX Earnings
$0.00
$0.09
$0.19
$0.28
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated$0.20 per share
Estimated$0.20 per share
ActualExpected Mar 15, After Hours
ActualExpected Mar 15, After Hours